NCT00354601 2017-08-30
Docetaxel and Capecitabine in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cavity Cancer
Wake Forest University Health Sciences
Phase 2 Terminated
Wake Forest University Health Sciences
Alliance for Clinical Trials in Oncology
Memorial Sloan Kettering Cancer Center